A set of transformative activities and investments is key to support delivery of the highest quality and most cost-effective care for patients, according an industry leader who spoke at the recently concluded Health Information and Management Systems Society (HIMSS) Asia Pacific Conference 2019.
How do health systems create value? This is the question posed by Dr Anne Snowdon, professor of strategy and entrepreneurship at Odette School of Business in Canada, at the recently concluded Asia Pacific Conference of the Health Information and Management Systems Society (HIMSS) 2019.
In providing value-based healthcare, the first step is to measure outcomes relevant to patients, according to a speaker who addressed healthcare professionals at the Health Information and Management Systems Society (HIMSS) Asia Pacific Conference 2019.
Focusing on value-based models of healthcare is the way forward, asserts Neil Patel, president of the consulting firm Healthbox, during his talk at the recently concluded Asia Pacific Conference of the Healthcare Information and Management Systems Society (HIMSS) 2019. This, he adds, may require reassessment of priorities and disruptions of the industry.
A digital-first approach, iConnect, allows patients to have greater access to services and guidance and enables healthcare providers to deliver much better postdischarge care, according to Lim Cher Wee, chief operating officer of the Ministry of Health, Office for Healthcare Transformation of Singapore, in his presentation at the recently concluded AsiaPac19 Conference & Exhibition of the Healthcare Information and Management Systems Society (HIMSS 2019).
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Doctor - Malaysia digital copy today!
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.